Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic use of Posaconazole (Noxafil) in adults with invasive resistant mycoses intolerant or refractory to standard therapy
2006-004968-32Phase 3Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of posaconazole in aspergillosis, fusariosis, chromoblastomycosis and 2 more, sponsored by IRCCS Ospedale San Raffaele. Started Jan 2007; status: terminated.
02
Drugs
posaconazole
03
Conditions
aspergillosisfusariosischromoblastomycosiscoccidioidomycosisinvasive mycoses
Beyond the preview
Go deeper on 2006-004968-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004968-32.